Bal Pharma Limited (BALPHARMA)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
93.95
-0.6(-0.63%)

Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostrate enlargement, renal calculi, male infertility, women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, etc.; and various formulations. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Pricing Updates

TODAY'S HIGH

95.8

TODAY'S LOW

92.85

52 WEEK HIGH

148.85

52 WEEK LOW

85.25

Major Holders

% of Shares Held by
All Insider

68.36%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

146.45 Cr.

ETERPRISE VALUE

236.76 Cr.

NO. OF SHARES

1.55 Cr.

BOOK VALUE

39.566

DIV. YIELD

1%

DEBT

103.63 Cr.

GROSS PROFIT

109.05 Cr.

CASH

5.39 Cr.

REVENUE

280.22 Cr.

REVENUE/SHARE

189.355

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-1.19 Cr.-91.11 Lakhs-91.11 Lakhs-91.11 Lakhs
Change To Liabilities20.31 Cr.8.98 Cr.-8.75 Cr.-2.61 Cr.
Total cashflows from Investing Activities-9.48 Cr.-4.98 Cr.-4.70 Cr.-8.04 Cr.
Net Borrowings-6.24 Cr.-8.92 Cr.-6.24 Cr.13.83 Cr.
Total Cash from Financing Activities-18.13 Cr.-16.63 Cr.-19.97 Cr.1.36 Lakhs
Other Liabilities5.25 Cr.-1.15 Cr.11.18 Cr.-1.25 Cr.
Total Assets03.25 Cr.3.25 Cr.3.25 Cr.
Net Income5.61 Cr.4.74 Cr.-12.21 Cr.3.78 Cr.
Change in Cash8.93 Lakhs16.47 Lakhs-1.57 Cr.-27.25 Lakhs
Effect of Exchange Rate0-36 k-14.23 Lakhs-14.23 Lakhs
Total Cash from Operating Activities27.70 Cr.21.78 Cr.23.24 Cr.7.75 Cr.
Depreciation9.04 Cr.8.33 Cr.6.34 Cr.4.62 Cr.
Other Cashflows from Investing Activities17.87 Lakhs30.22 Lakhs33.96 Lakhs53.22 Lakhs
Dividends Paid-1.48 Cr.-1.48 Cr.-1.41 Cr.-1.47 Cr.
Change to Inventory-14.01 Cr.7.32 Cr.2.03 Cr.-3.25 Cr.
Change to Account Receivables-9.88 Cr.-18.50 Cr.13.46 Cr.6.30 Lakhs
Other Cashflows from Financing Activities-10.40 Cr.-10.95 Cr.-12.30 Cr.-12.34 Cr.
Change to Net Income11.37 Cr.10.87 Cr.9.84 Cr.4.88 Cr.
Capital Expenditures-8.46 Cr.-3.41 Cr.-5.06 Cr.-8.59 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax9.18 Cr.4.10 Cr.-13.68 Cr.-20.24 Lakhs
Minority Interest-13.44 Lakhs-22.78 Lakhs-7.09 Cr.-6.42 Cr.
Net Income14.43 Cr.16.81 Cr.-2.73 Cr.11.39 Cr.
Selling General Administrative47.25 Cr.42.57 Cr.50.84 Cr.51.91 Cr.
Gross Profit113.68 Cr.96.38 Cr.83.44 Cr.104.02 Cr.
Ebit14.43 Cr.16.81 Cr.-2.73 Cr.11.39 Cr.
Operating Income14.43 Cr.16.81 Cr.-2.73 Cr.11.39 Cr.
Other Operating Expenses42.95 Cr.27.48 Cr.27.71 Cr.34.56 Cr.
Interest Expense-10.40 Cr.-10.53 Cr.-10.77 Cr.-10.88 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense3.47 Cr.-61 Lakhs-79.70 Lakhs-2.35 Cr.
Total Revenue281.21 Cr.250.52 Cr.171.09 Cr.225.01 Cr.
Total Operating Expenses266.77 Cr.233.71 Cr.173.83 Cr.213.61 Cr.
Cost of Revenue167.52 Cr.154.14 Cr.87.64 Cr.120.98 Cr.
Total Other Income Expense Net-5.25 Cr.-12.71 Cr.-10.95 Cr.-11.59 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.5.70 Cr.4.71 Cr.-12.89 Cr.2.15 Cr.
Net Income Applicable to Common Shares5.61 Cr.4.74 Cr.-12.21 Cr.3.78 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets7.99 Cr.5.91 Lakhs9.03 Lakhs9.74 Lakhs
Capital Surplus026.67 Cr.24.07 Cr.24.07 Cr.
Total Liabilities203.91 Cr.186.72 Cr.193.05 Cr.201.08 Cr.
Stock Holder Equity58.62 Cr.53.58 Cr.52.42 Cr.66.64 Cr.
Minority Interest-13.44 Lakhs-22.78 Lakhs-7.09 Cr.-6.42 Cr.
Other Liabilities22.85 Cr.11.80 Cr.16.82 Cr.12.99 Cr.
Total Assets262.40 Cr.240.08 Cr.238.38 Cr.261.30 Cr.
Common Stock14.82 Cr.14.82 Cr.14.17 Cr.14.17 Cr.
Retained Earnings011.90 Cr.15.03 Cr.28.96 Cr.
Other Liabilities11.25 Cr.8.64 Cr.9.29 Cr.9.08 Cr.
Good Will3.82 Cr.3.82 Cr.3.82 Cr.3.82 Cr.
Treasury Stock43.80 Cr.17.90 Lakhs-86.06 Lakhs-57.04 Lakhs
Other Assets6.88 Cr.12.15 Cr.11.87 Cr.7.36 Cr.
Cash5.39 Cr.1.02 Cr.85.87 Lakhs2.43 Cr.
Current Liabilities165.64 Cr.152.53 Cr.159.49 Cr.163.24 Cr.
Long Term Asset Charges1.87 Cr.000
Short Long Term Debt05.27 Cr.5.68 Cr.7.66 Cr.
Other Stockholder Equity43.80 Cr.17.90 Lakhs-86.06 Lakhs-57.04 Lakhs
Property Plant Equipment57.18 Cr.57.50 Cr.63.76 Cr.64.47 Cr.
Total Cur. Assets184.57 Cr.164.14 Cr.157.36 Cr.183.04 Cr.
Long Term Investments1.94 Cr.2.38 Cr.1.45 Cr.2.49 Cr.
Net Tangible Assets46.80 Cr.49.69 Cr.48.50 Cr.62.71 Cr.
Short Term Investments02.94 Cr.2.64 Cr.1.70 Cr.
Net Receivables77.66 Cr.74.05 Cr.55.39 Cr.71.10 Cr.
Long Term Debt27.01 Cr.23.93 Cr.23.14 Cr.28.75 Cr.
Inventory74.39 Cr.60.38 Cr.67.71 Cr.69.75 Cr.
Accounts Payable65.43 Cr.47.16 Cr.38.67 Cr.47.33 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account